ProCE Banner Activity

A Preview of CROI 2020: My Take on Hot Topics

Conference Coverage
Clinical Thought
Here are my picks for the most intriguing studies being presented at CROI 2020, including data on long-acting injectable ART, the cardiometabolic effects of INSTIs, and a randomized trial comparing dolutegravir vs efavirenz in pregnant women.

Released: March 06, 2020

Share

Provided by

Provided by the USF Health
ProCE Banner

Supporters

This activity is supported by educational grants from

Gilead

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Monica Gandhi, MD, MPH

Director, UCSF-Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
University of California, San Francisco (UCSF)
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant conflicts of interest to report.